The diagnostic process for cystic fibrosis (CF) in the presence of suspected or confirmed surgical site infection (SSI) requires a multi-faceted approach. This process aims to confirm the CF diagnosis, assess the severity of the disease, and identify any contributing factors to the SSI, ultimately guiding appropriate treatment strategies. Diagnostic methods are typically initiated based on clinical presentation, newborn screening results, or family history.
Accurate and timely diagnosis is critical for managing CF and its complications, including SSIs. Early identification allows for the prompt initiation of treatments to slow disease progression, manage symptoms, and improve quality of life. Furthermore, understanding the specific pathogen(s) involved in the SSI, their antibiotic sensitivities, and the patient’s overall health status are essential for tailoring effective antimicrobial therapy and preventing further complications. Historically, the diagnosis of CF relied heavily on clinical observation, but advances in genetic testing and sweat chloride testing have significantly improved diagnostic accuracy.
